Cargando…
New Developments in Carbonic Anhydrase IX-Targeted Fluorescence and Nuclear Imaging Agents
Carbonic anhydrase IX (CAIX) is a tumor-specific and hypoxia-induced biomarker for the molecular imaging of solid malignancies. The nuclear- and optical-imaging of CAIX-expressing tumors have received great attention due to their potential for clinical applications. Nuclear imaging is a powerful too...
Autores principales: | Chen, Kuo-Ting, Seimbille, Yann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181387/ https://www.ncbi.nlm.nih.gov/pubmed/35682802 http://dx.doi.org/10.3390/ijms23116125 |
Ejemplares similares
-
A Flexible Synthesis of (68)Ga-Labeled Carbonic Anhydrase IX (CAIX)-Targeted Molecules via CBT/1,2-Aminothiol Click Reaction
por: Chen, Kuo-Ting, et al.
Publicado: (2018) -
Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX
por: Lau, Joseph, et al.
Publicado: (2017) -
Targeting Carbonic Anhydrase IX Activity and Expression
por: Mahon, Brian P., et al.
Publicado: (2015) -
Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
por: McDonald, Paul C., et al.
Publicado: (2012) -
An update on anticancer drug development and delivery targeting carbonic anhydrase IX
por: Kazokaitė, Justina, et al.
Publicado: (2017)